Accelerating drug discovery through AI, automation, and next-generation DMTA

In this interview, industry experts Jon Wingfield and Wenshu Xu from TTP discuss the technologies and strategies transforming modern drug discovery. Drawing on decades of experience across pharmaceuticals, automation, and innovation, they explore how artificial intelligence, advanced data analytics, and increasingly autonomous laboratory systems are reshaping the design-make-test-analyze (DMTA) cycle. https://www.news-medical.net/news/20260619/Accelerating-drug-discovery-through-AI-automation-and-next-generation-DMTA.aspx?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=drug_discovery_newsletter_9_july_2026